NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma of the Extremity

clinical trial

Details

Instance of: clinical trial
Start time: October 2011
End time: May 2014
Country: France
Main subject: sarcoma
clinical trial phase: phase I clinical trial
minimum age: 18
number of participants: 22
research site: Institut Gustave Roussy
sponsor: Nanobiotix
study type: interventional study
title: An Open-Label, Single Arm, Feasibility And Safety Phase I Study With Nbtxr3 Intratumor Implantation (By Injection) And Activated By External Beam Radiation Therapy In Patients With Soft Tissue Sarcoma Of The Extremity And Trunk Wall

Nothing in the MetaHistoryBook collection references this item yet.